I-Medata AI Center, Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel; Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Department of Pathology, Duke University Medical Center, Durham, North Carolina.
Am J Pathol. 2023 Sep;193(9):1185-1194. doi: 10.1016/j.ajpath.2023.05.011.
Thyroid cancer is the most common malignant endocrine tumor. The key test to assess preoperative risk of malignancy is cytologic evaluation of fine-needle aspiration biopsies (FNABs). The evaluation findings can often be indeterminate, leading to unnecessary surgery for benign post-surgical diagnoses. We have developed a deep-learning algorithm to analyze thyroid FNAB whole-slide images (WSIs). We show, on the largest reported data set of thyroid FNAB WSIs, clinical-grade performance in the screening of determinate cases and indications for its use as an ancillary test to disambiguate indeterminate cases. The algorithm screened and definitively classified 45.1% (130/288) of the WSIs as either benign or malignant with risk of malignancy rates of 2.7% and 94.7%, respectively. It reduced the number of indeterminate cases (N = 108) by reclassifying 21.3% (N = 23) as benign with a resultant risk of malignancy rate of 1.8%. Similar results were reproduced using a data set of consecutive FNABs collected during an entire calendar year, achieving clinically acceptable margins of error for thyroid FNAB classification.
甲状腺癌是最常见的恶性内分泌肿瘤。评估术前恶性风险的关键检验是细针穿刺抽吸活检(FNAB)的细胞学评估。评估结果往往不确定,导致良性术后诊断的不必要手术。我们已经开发了一种深度学习算法来分析甲状腺 FNAB 全幻灯片图像(WSI)。我们在最大的甲状腺 FNAB WSI 报告数据集中展示了其在确定性病例筛查中的临床级性能,并表明其可作为辅助检验来消除不确定病例的指示。该算法筛选并明确分类了 45.1%(130/288)的 WSI 为良性或恶性,恶性风险率分别为 2.7%和 94.7%。它通过重新分类 21.3%(N=23)为良性,将不确定病例的数量减少了 21.3%(N=23),从而使恶性风险率降至 1.8%。使用一整年连续收集的 FNAB 数据集复制了类似的结果,实现了甲状腺 FNAB 分类的临床可接受的误差幅度。